Do epilepsy and psychiatric disorders share common pathogenic mechanisms? A look at depression and epilepsy

Clinical Neuroscience Research

Volumn 4, Issue 1-2, 2004, Pages 31-37

  Kanner, Andres M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hippocampal atrophy; Major depression; Norepinephrine; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMAZEPINE; DOPAMINE; GLUCOCORTICOID; LAMOTRIGINE; MONOAMINE OXIDASE INHIBITOR; NEUROTRANSMITTER; NORADRENALIN; PENTETRAZOLE; PHENYTOIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AMYGDALOID NUCLEUS; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN ATROPHY; CINGULATE GYRUS; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELECTRIC SHOCK; EPILEPSY; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; NORADRENERGIC SYSTEM; ORBITAL CORTEX; PATHOGENESIS; POSTSYNAPTIC POTENTIAL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROTONINERGIC SYSTEM; VAGUS NERVE STIMULATION;

EID: 17644406354     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2004.06.004     Document Type: Article

References (70)

1. Hermann B.P. Seidenberg M. Bell B. Psychiatric comorbidity in chronic epilepsy: Identification, consequences, and treatment of major depression Epilepsia 41 Suppl. 2 2000 S31-S41
2. Wiegartz P. Seidenberg M. Woodard A. et-al Co-morbid psychiatric disorder in chronic epilepsy: Recognition and etiology of depression Neurology 53 Suppl. 2 1999 S3-S8
3. Jacoby A. Baker G.A. Steen N.et-al The clinical course of epilepsy and its psychosocial correlates: Findings from a UK Community study Epilepsia 37 2 1996 148-161
4. O'Donoghue M.F. Goodridge D.M. Redhead K.et-al Assessing the psychosocial consequences of epilepsy: A community-based study Br J Gen Pract 49 440 1999 211-214
5. Edeh J. Toone B. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice Br J Psychiatry 151 1987 95-101
6. Blum D. Reed M. Metz A. Prevalence of major affective disorders and manic/hypomanic symptoms in persons with epilepsy: A community survey Neurology Suppl 3 2002 A-175
7. Forsgren L. Nystrom L. An incident case referent study of epileptic seizures in adults Epilepsy Res 6 1999 66-81
8. Hesdorffer D.C. Hauser W.A. Annegers J.F.et-al Major depression is a risk factor for seizures in older adults Ann Neurol 47 2000 246-2490
9. Hesdorffer D.C. Ludvigsson P. Hauser W.A. Olafsson E. Depression is a risk factor for epilepsy in children Epilepsia 39 1998 222A
10. Lewis A. Melancholia: A historical review J Mental Sci 80 1934 1-42
11. Mendez M.F. Cummings J. Benson D.et-al Depression in epilepsy. Significance and phenomenology Arch Neurol 43 1986 766-7700
12. Robertson M. Trimble M. Townsend H. et-al The phenomenology of depression in epilepsy Epilepsia 28 1987 364-372
13. Kogeorgos J. Fonagy P. Scott D.et-al Psychiatric symptom patterns of chronic epileptics attending a neurological clinic: A controlled investigation Br J Psychiatry 140 1982 236-244
14. Mungas D. Interictal behavior abnormality in temporal lobe epilepsy Arch Gen Psychiatry 39 1982 108-111
15. Mendez M. Engebrit D. Doss R. The relationship of epileptic auras and psychological attributes J Neuropsychiatry Clin Neurosci 8 1996 287-292
16. Gilliam F. Maton B. Martin R.C. et-al Extent of 1H spectroscopy abnormalities independently predicts mood status and quality of life in temporal lobe epilepsy Epilepsia 41 Suppl. 7 2000 54
17. Quiske A. Helmstaedter C. Lux S. et-al Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis Epilepsy Res 39 2 2000 121-125
18. Schmitz E.B. Moriarty J. Costa J.C. et-al Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: Interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy J Neurol Neurosurg Psychiatry 62 5 1997 458-463000
19. Sheline Y.I. Wang P.W. Gado M.H. et-al Hippocampal atrophy in recurrent major depression Proc Natl Acad Sci USA 93 9 1996 3908-3913
20. Sheline Y.I. Sanghavi M. Mintun M.A. et-al Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression J Neurosci 19 12 1999 5034-5043
21. MacQueen G.M. Campbell S. McEwen B.S. MacDonaald K. Amano S. Joff R.T. et-al Course of Illness, hippocampal Function, and hippocampal volume in major depression Proc Natl Acad Sci USA 100 3 2003 1387-1392
22. Bell-McGinty S. Butters M.A. Meltzer C.C. Greer P.J. Reynolds C.F.3rd Becker J.T. Brain morphometric abnormalities in geriatric depression: Long term neurobiological effects of illness duration Am J Psychiatry 159 8 2002 1424-1427
23. Vakili K. Pillay S.S. Lafer B. Fava M. Renshaw P.F. Bonello-Cintron C.M. Yurgelun-Todd D.A. Hippocampal volume in primary unipolar major depression: A magnetic resonance imaging study Biol Psychiatry 47 12 2000 1087-1090
24. Shah P.J. Ebmeier K.P. Glabus M.F. Goodwin G.M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study Br J Psychiatry 172 1998 527-532
25. Sheline Y.I. Sanghavi M. Mintun M.A. Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression J Neurosci 19 12 1999 5034-5043
26. Sheline Y.I. Gado M.H. Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression Neuroreport 9 9 1998 2023-2028
27. Frodl T. Meisenzahl E. Zetzsche T. Bottlender R. Born C. Groll C. Jager M. Leinsinger G. Hahn K. Moller H.J. Enlargement of the amygdala in patients with a first episode of major depression Biol Psychiatry 51 9 2002 708-714
28. Bowley M.P. Drevets W.C. Ongur D. Price J.L. Low glial numbers in the amygdala in major depressive disorder Biol Psychiatry 52 5 2002 0404-412
29. EBaxter L.R. Schawrtz J.M. Phelps M. M. Mazziotta J.C. Guze B.H. Selin C.E. et-al Reduction of the prefrontal cortex glucose metabolism common to three types of depression Arch Gen Psychiatry 46 1989 243-250
30. Baxter L.R. Phelps M.E. Mazziotta J.C. Guze B.H. Schwartz J.M. Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: A comparison with rates in unipolar depression and in normal controls Arch Gen Psychiatry 44 1987 211-218
31. Menzel C. Grunwald F. Klemm E. Ruhlmann J. Elger C.E. Biersack H.J. Inhibitory effect of mesial temporal partial seizures onto frontal neocortical structures Acta Neurol Belg 98 1998 327-331
32. Hermann B.P. Wyler A.R. Richey E.T. Wisconsin card sorting test performance in patients with complex partial seizures of temporal-lobeorigin J Clin Exp Neuropsychol 10 1988 467-476
33. Bremner J.D. Vithilingham M. Vermetten E. Nazeer A. Adil J. Khan S. Staib L.B. Charney D.S. Reduced volume of orbitofrontal cortex in major depression Biol Psychiatry 51 2002 273-279
34. Coffey C.E. Wilkinson W.E. Weiner R.D. et-al Quantitative cerebral anatomy in depression: A controlled magnetic resonance imaging study Arch Gen Psychiatry 50 1993 7-16
35. Rajkowska G. Miguel-Hidalgo J.J. Wei J. Dilley G. Pittman S.D. Meltzer H.Y. Overholser J.C. Roth B.L. Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biol Psychiatry 45 9 1999 1085-1098
36. Taylor W.D. Steffens D.C. McQuoid D.R. Payne M.E. Lee S.H. Lai T.J. Krishnan K. Smaller orbital frontal cortex volumes associated with functional disability in depressed elders Biol Psychiatry 53 2 2003 144-149
37. Lai T. Payne M.E. Byrum C.E. Steffens D.C. Krishnan K. Reduction of orbital frontal cortex volume in geriatric depression Biol Psychiatry 48 10 2000 971-975
38. Kumar A. Zhisong J. Warren B. Jayaram U. Gottlieb G. Late-onset minor and major depression: Early evidence for common neuroanatomical substrates detected by using MRI Proc Natl Acad Sci USA 95 13 1998 7654-7658
39. Hecimovic H. Goldstein J. Sheline Y. Gilliam F. Mechanisms of depression in epilepsy Epilepsy Behav 2003
40. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: Implications for therapy J Affect Disord 62 2001 77-91
41. Holsboer F. Corticotropin-releasing hormone modulators and depression Curr Opin Invest Drugs 4 2003 46-50
42. Reul J.M. Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression Curr Opin Pharmacol 2 2002 23-330
43. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 57 2000 925-9350
44. Fuchs E. Gould E. Mini-review: In vivo neurogenesis in the adult brain: Regulation and functional implications Eur J Neurosci 12 2000 2211-2214
45. Lucassen P.J. Muller M.B. Holsboer F. Bauer J. Holtrop A. Wouda J. et-al Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure Am J Pathol 158 2001 453-468
46. Shirayama Y. Chen A.C. Nakagawa S. Russell D.S. Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J Neurosci 22 2002 3251-3261
47. Smith M.A. Makino S. Kvetnansky R. Post R.M. Effects of stress on neurotrophic factor expression in the rat brain Ann NY Acad Sci 771 1995 234-239
48. Nibuya M. Morinobu S. Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 15 1995 7539-7547
49. Chen B. Dowlatshahi D. MacQueen G.M. Wang J.F. Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol Psychiatry 50 2001 260-265
50. Schildkraut J.J. The catecholamine hypothesis of effective disorders: a review of supporting evidence Am J Psychiatry 122 1965 509-522
51. Jobe P.C. Dailey J.W. Wernicke J.F. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders Crit Rev Neurobiol 13 1999 317-356
52. Jobe P.C. Mishra P.K. Adams-Curtis L.E. et-al The genetically epilepsy-prone rat (GEPR) Ital J Neurol Sci 16 1995 910
53. Lehmann A. Audiogenic seizures data in mice supporting new theories of biogenic amines mechanisms in the central nervous system Life Sci 6 1967 1423
54. Yanagita T. Wakasa Y. Kiyohara H. Drug-dependance potential of viloxazine hydrochloride tested in rhesus monkeys Pharmacol Biochem Behav 12 1980 155
55. Lewis J.J. Rauwolfia derivates. In: Root W.S. Hofmann F.G. (eds.), Physiological pharmacol 1974 Academic press New York0
56. Maynert E.W. Marczynski T.J. Browining R.A. The role of the neurotransmitters in the epilepsies. In: Friedlander W.J. (Ed.), Advance in neurology 1975 Raven press New York
57. Naidoo D0. The effects of reserpine (serpasil) on the chronic disturbed schizophrenic: A comparative study of rauwolfia alkaloids and electroconvulsive therapy J Nerv Mental Dis 1956 123
58. Noce R.H. Williams D.B. Rapaport W. Reserpine (serpasil) in management of the mentally ill J Am Med Assoc 158 1955 11
59. Tasher D.C. Chermak M.W. The use of reserpine in shock-reversible patients and shock-resistent patients Ann NY Acad Sci 61 1955 108
60. Berg S. Gabriel A.R. Impastato D.J. Comparative evaluation of the safety of chlorpromazine and reserpine used in conjuction with ECT J Neuropsychiatry 1 1959 104
61. Fromm G.H. Rosen J.A. Amores C.Y. Clinical and experimental investigation of the effect of imipramine on epilepsy Epilepsia 12 1971 282
62. Fromm G.H. Wessel H.B. Glass J.D. Alvin J.D. VanHorn G. Imipramine in absence and myoclonic-astatic seizures Neurology 28 1978 953
63. Fromm G.H. Amores C.Y. Thies W. Imipramine in epilepsy Arch Neurol 27 1972 198
64. Ojemann L.M. Friel P.N. Trejo W.J. Dudley D.L. Effect of doxepin on seizure frequency in depressed epileptic patients Neurology 33 1983 66
65. Favale E. Rubino V. Mainardi P. Lunardi G. Albano C. The anticonvulsant effect of fluoxetine in humans Neurology 45 1995 1926
66. Dailey J.W. Reith M.E.A. Yan Q.S. Li M.Y. Jobe P.C. Anticonvulsant doses of carbamezapine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats;dose response relationships Neurosci Lett 227 1997 13
67. Southam E. Kirkby D. Higgens G.A. Hagan R.M. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytriptamine uptake in rats Eur J Pharmacol 358 1998 19
68. Naritokku D.K. Terry W.J. Helfert R.H. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve Epilepsy Res 22 1995 53
69. Browning R.A. Clark K.B. Naritoku D.K. Smith D.C. Jensen R.A. Loss of anticonvulsant effect of vagus nerve stimulation in the pentylenetetrazol seizure model following treatment with 6-hydroxydopamine or 5,7-dihydroxy-tryptamine Soc Neurosci 23 1997 2424
70. Mohanraj R. Brodie M.J. Predicting outcomes in newly diagnosed epilepsy Epilepsia 44 Supp. l9 2003 15